Back to results
US 2025/0326752 A1Published application
Piperidinyl-methyl-purine amine salts, crystalline forms, and their use in treating medical diseases and conditions
AssigneesK36 Therapeutics, Inc., Novartis AG
InventorsTerrence Joseph Connolly, Chad Arthur Lewis, Tengfei Li, Xuan Dai, Lijun Zhang
Life of this patent
Estimating the term…
Abstract
The invention provides piperidinyl-methyl-purine amine salts, crystalline forms, pharmaceutical compositions, their use in inhibiting NSD2, and their use in the treatment of a disease or condition, such as cancer.
Claims55
A compound represented by Formula I:
- wherein X is hydrochloric acid, sulfuric acid, succinic acid, citric acid, L-malic acid, or L-tartaric acid.
A crystalline form of a compound of Formula II:
Dependencies are inferred from the claim text.